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A series of copper (II) complexes of Schiff bases derived from 7H-2,6-diaminopurine and 4H-3,5-diamino-
1,2,4-triazole with 2-pyridinecarbaldehyde, salicylaldehyde, 2,4-dihydroxybenzaldehyde and 2-hydroxy-
1-naphthaldehyde have been prepared. The donor atoms and the possible geometry of the complexes
were investigated by means of elemental and thermal analyses, molar conductance, magnetic moment,
UV–Vis, IR, ESR and mass spectra. The ligands behaved as tetradentate, coordinating through the nitrogen
atom of the azomethine group and the nearest nitrogen atom to it or oxygen atom of a-hydroxyl group.
The results of simultaneous DTA & TGA analyses of the complexes showed the ﬁnal degradation product
for these complexes is CuO. The spectral studies conﬁrmed a four coordinate environment around the
metal ion. The obtained results were supported by 3D molecular modeling of complexes using molecular
mechanics (MM+) and semiempirical molecular orbital calculations (PM3). These complexes were also
tested for their in vitro antimicrobial activities against some bacterial and fungal strains. Complex 2
was investigated for its cyctotoxic effect against human breast cancer (MCF7), liver carcinoma (HEPG2)
and colon carcinoma cell lines (HCT116). This compound exhibited a moderate activity against the tested
cell lines with IC50 of 10.3, 9.8 and 8.7 lg/ml against MCF7, HCT116 and HEPG2, respectively.
 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Nitrogen-containing ligands such as Schiff bases and their metal
complexes played an important role in the development of coordi-
nation chemistry resulting in an enormous number of publications,
ranging from pure synthetic work to physicochemical [1] and bio-
chemically relevant studies of metal complexes [2–6] and found
wide range of applications. Other kinds of nitrogen-containing li-
gands are well-known pyrimidine systems such as the purine
bases (constituents of the nucleic acids) and their derivatives.
These compounds also are of great importance to chemists as well
as to biologists as they have been found in a large variety ofnaturally occurring compounds and also in clinically useful mole-
cules having diverse biological activities [7–9]. Purine bases mod-
iﬁed in the 6-position and their derivatives and analogues possess
a wide range of biological properties such as antitubercular, fungi-
cidal, antiallergic, antimicrobial, antitumor, antihistamic as well as
myocardium inhibiting agent [10–18]. In last few years the interac-
tion of metal ions with nucleic acids has been very active area of
inorganic and structural chemistry [9]. The study of metal coordi-
nation with the purines reveals in vitro the mechanism of their
coordination with DNA [19]. Also, triazoles and their derivatives
represent a very interesting class of compounds because of their
wide applications as antifungal [20], antibacterial [21], anticancer
[22] and antiviral [23] compounds, therefore Schiff bases contain-
ing a triazole moiety and their metal complexes are expected to be
bioactive compounds [24–26].
It has long been known that metal ions involved in biological
processes of life and have been a subject of interest. Among metals,
Copper is one of the essential trace elements present in living
organisms. It also exhibits considerable biochemical action as a
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humans. In its latter role it is bound to ligands of various types
forming complexes that interact with biomolecules, mainly
proteins and nucleic acids. Current interest in Cu complexes is
stemming from their potential use as antimicrobial, antiviral,
anti-inﬂammatory and antitumor agents, enzyme inhibitors or
chemical nucleases [27,28]. A number of Cu(II) chelate complexes
that exhibit cytotoxic activity through cell apoptosis or enzyme
inhibition have been reviewed [29]. Such complexes containing
bi-Schiff bases as ligands are effective in reducing tumor size,
delaying of metastasis and signiﬁcant increasing survival of the
hosts [29].
In attempt to obtain more insight into the bioactivity of nitro-
gen containing Schiff bases compared with their metal complexes,
herein, we have synthesized and characterized a series of purine
and 1,2,4-triazole-based Schiff bases and their copper(II) com-
plexes. The in vitro antibacterial, antifungal and anti-tumor activ-
ity of some selected compounds has been investigated.
2. Experimental
2.1. Materials and methods
Elemental analyses were performed by the aid of Perkin-Elmer
2400 CHN Elemental analyzer. The metal content of the complexes
was determined by atomic absorption spectroscopy using Perkin–
Elmer 2380 atomic absorption spectrophotometer after complete
decomposition of the complexes in conc. HNO3 several times. IR
spectra were recorded on a Perkin Elmer 1430 instrument (KBr
discs) in the 4000–200 cm1 range. Electronic spectra were ob-
tained with a Shimadzu UV–Vis. 240 spectrophotometer using Nu-
jol mull technique. The ESR spectra of powder samples were
recorded by means of a Jeol model JES-FE 2XG spectrometer
equipped with an E101 microwave bridge. Diphenyl picrylhydrazyl
(DPPH) was used as a reference material (g = 2.0023). The molar
conductance measurements were carried out at room temperature
using Hanna 8733 conductivity meter. The room temperature mag-
netic susceptibility was measured using magnetic susceptibility
balance (Johnson Mtthey) 436 Devon Park Drive. The thermal anal-
yses (TGA and DTA) were performed using computerized Shimadzu
TG-50 thermal analyzer up to 800 C at a heating rate 10 C/min.
under nitrogen atmosphere.
2.2. Preparation of ligands L1–3
To a solution of 7H-2,6-diaminopurine (0.001 mol,0.15 g) in
20 ml ethanol, a solution of 2-pyridinecarbaldehyde (0.002,
0.214 g), 2,4-dihydroxy-1-naphthaldehyde (0.002,0.138 g) or
2-hydroxy-1-naphthaldehyde (0.002,0.172 g) in ethanol (20 ml)HN
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Fig. 1. A schematic representation of ligands uwas added. The resulting mixtures were then reﬂuxed with stirring
for 6 h. the products, which separated out on hot, were ﬁltered
of, washed with ethanol and dried over anhydrous CaCl2 (Yield:
64–77%).
2.3. Preparation of ligands L4–7
A similar procedures as that described above for synthesis of
L1–3 were carried out, by mixing an ethanolic solution of 4H-3,5-
diamino-1,2,4-triazole (0.001 mol, 0.099 g and 20 ml) and 20 ml
ethanolic solution of 2-pyridinecarbaldehyde (0.002,0.214 g), sali-
cylaldehyde (0.002,0.122 g), 2,4-dihydroxy-1-naphthaldehyde
(0.002,0.138 g) or 2-hydroxy-1-naphthaldehyde (0.002,0.172 g).
The resulting mixtures were also reﬂuxed with stirring for 6 h.
the products, which separated out on hot, were ﬁltered of, washed
with ethanol and dried over anhydrous CaCl2 (Yield: 66–84%). The
prepared Schiff bases (L1–L7) have the following structural formu-
lae (Fig. 1).
2.4. General procedure for synthesis of Cu(II) complexes
Toamagnetically and reﬂuxed solutionof the ligands (0.001 mol)
in DMF solution (30 ml), a solution of CuCl2.2H2O (0.002 mol) in
ethanol (10 ml) was added. The resulting mixtures were ﬁltered
and reduced to half of their volume by evaporation of the solvent.
The concentrated solutions were left overnight at room tempera-
ture,which led to the formationof a solid product. Theywereﬁltered
off, washed with a small amount of ether and dried over anhydrous
CaCl2.
2.5. Molecular modeling studies
An attempt to gain a better insight on the molecular structure of
Metal complexes, geometric optimization and conformational anal-
ysis has been performed by the use of MM+ force ﬁeld as imple-
mented in hyperchem 8.0 [30]. Semi empirical method PM3 is
then used for optimizing the full geometry of the system using Po-
lak–Ribiere (conjugate gradient) algorithm and Unrestricted Har-
tee–Fock (UHF) is employed keeping RMS gradient of 0.01 kcal/
mol. All the calculations refer to isolated molecules in vacuum.
2.6. Antibacterial studies
The in vitro antimicrobial activity of some selected compounds
has been investigated using a modiﬁed Kirby–Bauer disc diffusion
method [31]. Brieﬂy, 100 ll of the test bacteria/fungi were grown
in 10 ml of fresh media until they reached 108 cells/ml for bacteria
or 105 cells/ml for fungi [32]. 100 ll of microbial suspension was
spread onto agar plates corresponding to the broth in which theyN
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playing a pathogenic role should be selected from primary agar
plates and tested for susceptibility by disc diffusion method [33].
From the many media available, NCCLS recommends Mueller–
Hinton agar since it results in good batch-to-batch reproducibility
and also it is non-selective and non-differential medium which
means that almost all organisms plated on here will grow. Disc dif-
fusion method for ﬁlamentous fungi tested by using approved
standard method (M38-A) developed by the NCCLS [34] for evalu-
ating the susceptibilities of ﬁlamentous fungi to antifungal agents.
Disc diffusion method for yeasts developed by using approved
standard method (M44-P) by the NCCLS [35]. The antibacterial
and antifungal activities were done at concentration of 1 mg/ml
of the tested compounds in DMSO solvent. Plates inoculated with
ﬁlamentous fungi as Aspergillus ﬂavus NRRL 6554 at 25 C for
48 h; Gram positive bacteria as Staphylococcus aureus NCTC 6356
and Gram negative bacteria as Escherichia coli NRRL-B-3704. They
were incubated at 35–37 C for 24–48 h and yeast as Candida albi-
cans ATCC 10231 incubated at 30 C for 24–48 h and, then the
diameters of the inhibition zones were measured in millimeters
[36]. Standard discs of tetracycline (antibacterial agent) and
amphotericin B (antifungal agent) served as positive controls for
antimicrobial activity but ﬁlter discs impregnated with 10 ll of
solvent (distilled water, DMSO) were used as a negative control.
The agar used is Mueller–Hinton agar that is rigorously tested for
composition and pH. Further the depth of the agar in the plate is
a factor to be considered in the disc diffusion method. This method
is well documented and standard zones of inhibition have been
determined for susceptible and resistant values. Blank paper disks
(Schleicher & Schuell Spain) with a diameter of 8.0 mm were
impregnated 10 ll of tested concentration of the stock solutions.
When a ﬁlter paper disc impregnated with a tested chemical is
placed on agar the chemical will diffuse from the disc into the agar.
This diffusion will place the chemical in the agar only around the
disc. The solubility of the chemical and its molecular size will
determine the size of the area of chemical inﬁltration around the
disc. If an organism is placed on the agar it will not grow in the area
around the disc if it is susceptible to the chemical. This area of no
growth around the disc is known as a ‘‘Zone of inhibition’’ or ‘‘Clear
zone’’. For the disc diffusion, the zone diameters were measured
with slipping calipers of the National Committee for Clinical Labo-
ratory Standards [36].
2.7. Measurement of potential cytotoxicity by SRB assay
Three human cancer cell lines were used for in vitro screening
experiments; breast cancer (MCF7), colon carcinoma (HCT116) and
liver Carcinoma (HEPG2) cell lines. They were obtained frozen in li-
quid nitrogen (180 C) from the American Type Culture Collection.
The tumor cell lines were maintained in the National Cancer Insti-
tute, Cairo, Egypt, by serial sub-culturing. Potential cytotoxicity of
the compounds was tested using Skehan et al. method [37]. Cells
were plated in 96-multiwell plate (104 cells/well) for 24 h before
treatment with the compound to allow attachment of cell to the
wall of the plate. Different concentration of the compounds under
test (0, l, 2.5, 5, l0, 15, 20 and 50 lg/ml) were added to the cell
monolayer triplicate wells were prepared for each individual dose.
Monolayer cells were incubated with the compounds for 48 h at
37 C and in atmosphere of 5% CO2. After 48 h, Cells were ﬁxed,
washed and stained with Sulfo-Rhodamine-B stain. Excess stain
was washed with acetic acid and attached stain was recovered with
Tris EDTA buffer. Color intensity was measured in an ELISA reader.
The relation between surviving fraction and drug concentration is
plotted to get the survival curve of each tumor cell line after the
speciﬁed compound. An Elisa reader (TECAN SUNRISE), Potential
cytotoxicity of the compounds was measured in (PharmacologyUnit, Cancer Biology Department, National Cancer Institute, Cairo
University). Doxorubicin was used as standard cytotoxins.3. Results and discussion
3.1. Molar conductivity measurements
The molar conductance values of 103 M solution of the metal
complexes in DMF were calculated at room temperature (Table
1). The non-electrolytic nature of the metal complexes was con-
ﬁrmed by the low molar conductance values measured for DMF
solution of the compounds [38] (KM = 12.6–22.9X1 cm2 mol1).
3.2. 1H NMR spectra of the ligands
1H NMR spectra of the Schiff bases (L1–L7) were recorded in
d6-DMSO (Table 2). The 1H-NMR spectra of the ligands exhibited
a multiple within the range 6.72–8.34 ppm which assigned to aro-
matic protons. The azomethine protons (ACH@NA) appeared as a
singlet at 8.92–9.51 ppm. All the ligands, except L1 and L4, showed
a peak at 10.34–11.21 ppm, belonging to the phenolic OH protons
[39]. The most downﬁeld signals observed as a singlet is due to NH
protons of purine and triazole moieties and appeared at 12.81–
13.87 [40].
3.3. IR spectra
Veriﬁcation of the structure of metal complexes can be easily
achieved by comparing the IR spectra of the free ligands with their
metal complexes (Table 2). Such comparison revealed that the
absorption band appearing in the ligands spectra at 1617–
1573 cm1 due to the azomethine group is shifted to lower or
higher wavenumbers by 8–26 cm1 in the complexes spectra, sug-
gesting coordination through the azomethine nitrogen [41]. On the
other hand, the ligand band at 1655–1617 cm1 which assigned to
t(C@N) of the ring appears, almost at the same position, in the
spectra of complexes. In the case of complexes 1 and 4, this band
is shifted to lower wanvenumbers revealing the coordination of
the C@N of pyridine ring to the copper ion. These observations
are supported by the appearance of a non-ligand bands at 480–
407 cm1, which were tentatively assigned to the m(MAN) mode
[42]. The phenolic CAO of the free ligands is observed at 1299–
1239 cm1 [43]. Upon chelation, this band is shifted to lower or
higher values by 10–47 cm1 indicating the participation of the
oxygen atom of phenolic group in coordination to the metal ion.
Moreover, according to properties of non-electrolytic nature of
the metal complexes, it can be inferred that deprotonated phenolic
oxygen coordinates to metal ions due to the satisfaction of the
bivalency of the metal ions. The new bands appearing at 589–
512 cm1 assigned to m(MAO) band [42]. The appearance of a
broad band within 3463–3385 cm1 range in the spectra of hy-
drated complexes are assigned to m(OH) of water molecules at-
tached to the metal center.
3.4. EI-mass spectra
The constitutions and purities of the prepared complexes are
conﬁrmed using the electron impact mass spectrometry. Fig. 2 rep-
resents the mass spectrum of complex 1, as a representative exam-
ple. The mass spectrum of this complex [Cu2L1Cl3], showed a peak
at m/z 560 corresponding to the molecular ion peak of the
compound. The peaks observed at m/z 491 and 453 assigned to
[Cu2L1Cl] and [Cu2L1], respectively. The intensity ratios of the
observed peaks around 560, 490 and 453 are consistent with the
isotopic distributions for Cu2Cl3, Cu2Cl and Cu2 containing
Table 2
IR and 1H NMR spectral bands of the ligands and their Cu(II) complexes.
Comp. IR spectra (cm1) 1H NMR spectra (ppm)
m(OH) or m(H2O) m(NH) m(C@N) (ring) m(C@N) (imine) m(CAO) m(MAO) m(MAN) dHN dOH dCH@N dArAH
L1 – 3363 1655 1600 – – – 13.68 – 9.35 7.21–7.92
1 – – 1638 1592 – – 480 – – – –
L2 3463 3357 1649 1617 1239 – – 13.87 10.85, 10.34 9.12
2 3386 3323 1647 1593 1221 520 453 – – – –
L3 3423 3318 1655 1595 1299 – – 12.98 10.56 9.39 7.44–8.34
3 3400 3313 1655 1611 1289 589 477 – – – –
L4 – 3311 1617 1580 – – – 12.95 – 8.92 6.72–7.81
4 3366 3237 1596 1560 – – 413 – – – –
L5 3385 3312 1644 1573 1274 – – 12.81 11.21 9.51 6.95–7.84
5 3398 3329 1644 1555 1232 512 463 – – – –
L6 3459 3344 1629 1585 1261 – – 13.41 10.91, 10.52 9.32 6.81–7.92
6 3397 3301 1630 1611 1297 547 407 – – – –
L7 3430 3200 1631 1583 1245 – – 12.98 11.21 9.22 7.35–8.32
7 3417 3244 1629 1609 1292 523 455 – – – –
Table 1
Analytical and physical data of organic ligand and their metal complexes.
No. Compound (Empirical formula) Color (Km)a m.p (C) (%Yield) M. Wt. Elemental analysis found (Calc.)
%C %H %N %M
L1 C17H12N8 Faint yellow 250 328.33 62.63 3.27 34.55 –
(–) 71 (62.19) (3.68) (34.13)
L2 C19H14N6O4 Orange 280 390.35 58.13 3.74 21.84 –
(–) 64 (58.46) (3.61) (21.53)
L3 C27H18N6O2 Orange >300 458.47 70.27 3.84 18.24 –
(–) 77 (70.73) (3.96) (18.33)
L4 C14H11N7 Greenish yellow >300 277.28 60.33 3.79 35.64 –
(–) 72 (60.64) (4.00) (35.36)
L5 C16H13N5O2 Deep yellow 293 307.31 62.87 4.44 22.42 –
(–) 84 (62.53) (4.26) (22.79)
L6 C16H13N5O4 Orange >300 339.31 56.35 3.54 20.39 –
(–) 66 (56.64) (3.86) (20.64)
L7 C24H17N5O2 Yellow 277 407.42 70.57 3.95 17.32 –
(–) 78 (70.75) (4.21) (17.19)
1 [Cu2L1Cl3] Greenish grey >300 560.77 36.61 2.23 19.63 22.36
(C17H11Cl3Cu2N8) (18.6) 68 (36.41) (1.98) (19.98) (22.66)
2 [Cu2L2Cl2(H2O)2] Greenish grey >300 622.36 36.23 2.81 13.62 20.18
(C19H16Cl2Cu2N6O6) (12.6) 67 (36.67) (2.59) (13.50) (20.42)
3 [Cu2L3Cl2(H2O)2] Brown >300 690.48 47.27 2.72 12.54 18.10
(C27H20Cl2Cu2N6O4) (13.7) 71 (46.97) (2.92) (12.17) (18.41)
4 [Cu2L4Cl4](H2O)2 Green >300 582.22 28.59 2.24 16.52 21.64
(C14H15Cl4Cu2N7O2) (22.9) 65 (28.88) (2.60) (16.84) (21.83)
5 [Cu2L5Cl2(H2O)2] Brown >300 539.32 35.27 2.57 13.20 23.16
(C16H15Cl2Cu2N5O4) (15.8) 69 (35.63) (2.80) (12.99) (23.57)
6 [Cu2L6Cl2(H2O)2] Brown >300 571.32 33.89 2.12 12.49 22.81
(C16H15Cl2Cu2N5O6) (12.9) 64 (33.64) (2.65) (12.26) (22.25)
7 [Cu2L7Cl2(H2O)2]0.5H2O Deep brown 162 648.44 44.56 3.25 11.31 19.37
(C24H20Cl2Cu2N5O4.5) (14.2) 66 (44.45) (3.11) (10.8) (19.60)
a (O1 mol1 cm2).
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atoms conﬁrm that the chlorine atom attached to the metal ion
with a covalent bond [44]. For the other metal complexes, the
peaks observed at m/z 622, 690, 582, 539, 571 and 648 for com-
plexes 2, 3, 4, 5, 6 and 7 respectively, corresponded to the molec-
ular ion peak of these complexes. The results of both elemental
analyses and MS of the prepared complexes are in satisfactory
agreement with each other’s which conﬁrm the proposed molecu-
lar formula (Table 1).
3.5. Thermal behavior of metal complexes
The thermal behavior of some selected metal complexes was
characterized on the basis of TG and DTA methods. Thermoanalyt-
ical data of the complexes are given in Table 3; the TG/DTA ther-
mograms of complexes 2 and 4, as representative examples, arerepresented in Fig. 3. From this table it is clear that all the metal
complexes underwent thermal decomposition within three or four
steps. The Cu(II) complex 2 decomposed in four steps. The ﬁrst step
occurred within the range 37–145 C and corresponded to the loss
of coordinated water molecules. This step associated with endo-
thermic DTA peak at 102 C. The second and third steps of decom-
position appeared within the temperature ranges 145–239 and
239–385 C and corresponded to the loss of coordinated chloride
ions and partial decomposition of the ligand with the loss of two
AOH groups. These step associated with exothermic DTA peak with
maximum at 218 C. The organic ligand was further decomposed
within the temperature range 385–576 C leaving behind CuO as
ﬁnal product.
The Cu(II) complexes 4 decomposed in four steps. The ﬁrst step
occurred within the range 34–115 C and corresponded to the loss
of lattice water molecule. This step of decomposition associated
Fig. 2. Mass spectra of complex 1.
Table 3
Thermal analyses (DTA and TGA) of the metal complexes.
No. Complex TG range (C) DTA max (C) (Calc.) found mass loss % assignment
2 [Cu2L2Cl2(H2O)2] 37–145 102() (5.78) 5.91 – Loss of two coordinated water
(622.36) 145–239 218(+) (5.70) 5.44 – Loss of one coordinated chloride ion
239–385 – (11.16) 11.77 – Loss of one coordinated chloride ion with two AOH
385–576 540() (51.51) 51.57 – Further decomposition of ligand leaving CuO residue
4 [Cu2L4Cl4](H2O)2 34–115 55() (3.09) 2.84 – Loss of one lattice water
(582.22) 115–257 189(+) (9.18) 8.98 – Loss of one lattice water and one coordinated chloride
257–344 255() (18.29) 17.93 – Loss of 3 coordinated chloride ions
344–550 538(+) (47.62) 47.14 – decomposition of ligand leaving CuO residue
5 [Cu2L5Cl2(H2O)2] 31–150 112() (6.67) 6.85 – Loss of two coord. H2O
(539.32) 150–264 214(+) (25.41) 25.79 – Loss of two coord. Cl and triazole ring
264–380 280(+) (10.01) 9.76 – loss of two azomethine groups
380–538 416(+) (28.22) 28.63 – further decomposition of ligand leaving CuO residue
6 [Cu2L6Cl2(H2O)2] 31–147 104() (6.30) 6.06 – Loss of two coord. H2O
(571.32) 147–311 230(+) (12.42) 12.98 – Loss of two coord. Cl
311–616 290(+) (53.38) 53.21 – decomposition of ligand leaving CuO residue
7 [Cu2L7Cl2(H2O)2]0.5H2O 31–104 98() (1.38) 1.55 – Loss of lattice water
(648.44) 104–388 – (16.50) 16.21 – Loss of coordinated water and chloride
388–629 395(+) (57.58) 57.89 – decomposition of ligand leaving CuO residue
Fig. 3. TG/DTA thermograms of complex 2 (a) and complex 4 (b).
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sition appeared within the temperature range 115–257 C and cor-
responded to the loss of one lattice water and one coordinated
chloride ion. This step associated with exothermic DTA peak at
189 C. The third step occurred at 257–344 C and corresponded
to the loss of coordinated chloride ion with endothermic DTA peak
at 255 C. The last step appeared at 344–550 C and corresponded
to decomposition of the organic ligand with the formation of CuO
as ﬁnal product. This step associated with exothermic DTA peak at
538 C.
For the complexes 5 and 6, the ﬁrst step of decomposition oc-
curred within the ranges 31–150 and 31–147 C, respectively,
and corresponded to the loss of coordinated water molecules.
These steps accompanied with DTA peaks at 112 and 104 C for
complexes 5 and 6, respectively. The second step of decomposition
appeared at 150–264 and 147–311 C associated with DTA peak at
214 and 230 C for the complexes 5 and 6, respectively. This step of
decomposition corresponded to the loss of coordinated chloride
ions. Complex 5 further decomposed in two steps within the range
264–380 and 380–538 C associated with DTA peaks at 280 and
416 C while the last step of decomposition for complex 6
appeared at 311–616 C with DTA peak at 290 C resulting in the
formation of CuO as ﬁnal product.
Complex 7 decomposed in three steps, the ﬁrst step appeared at
31–104 C and corresponded to the loss of lattice water with endo-
thermic DTA peak at 98 C. The second step of decomposition
appearing at 104–388 C assigned to the loss of coordinated water
and chloride. The third step appeared at 388–629 C corresponding
to the decomposition of the organic ligand with the formation of
CuO as ﬁnal product. This step accompanied with exothermic
DTA peak at 395 C. As shown in Table 3, the calculated mass loss
of each step of decomposition is in a good agreement with the
found ones which conﬁrm the proposed structures.
3.6. Magnetic moments and electronic spectra
The information regarding the geometry of the metal complexes
was obtained from their electronic spectral data and magnetic mo-
ments. The UV–Vis spectral data of all the metal complexes are gi-
ven in Table 4. The electronic spectral data of complexes 2, 3, 5, 6
and 7 in the solid state showed three absorption bands above
300 nm, centered approximately within the ranges 370–400,
480–485 nm and 632–645 nm. The absorption within the range
480–485 nm is likely to be due to charge transfer from the nitrogen
atoms to the copper ions [45]. The broad band appearing at 632–
645 nm is identiﬁed to the complex itself with d–d electronic
(2T2? 2E) transitions [46,47] assuming distorted tetrahedral
geometry around Cu(II). In the case of square planar copper
complexes, three allowed transitions are expected in the visible
region, but often these theoretical expectations are overlooked in
practice, and these bands usually appear overlapped as a broad ﬂap
band due to the very small energy difference between the d levels
[48]. The electronic spectra of the Cu(II) complexes 1 and 4 showed
a broad band appearing at 680 and 665 nm for 1 and 4, respec-
tively, due to the d–d (B1g? A1g) transition expected for squareTable 4
Magnetic moment, electronic and ESR spectral data of metal complexes.
Comp. k (nm) leff (B.M.)
1 220, 240, 345, 420, 509, 680 1.39
2 380, 485, 625 1.34
3 370, 480, 640 1.21
4 222, 261, 350, 420, 480, 665 1.31
5 385, 480, 640 1.34
6 370, 485, 632 1.26
7 400, 480, 635 1.24planar Cu (II) complexes [49,50]. The two bands appearing at 420
& 509 nm for complex 1 and 420 & 480 nm for complex 4 were as-
signed to charge transfer transitions. The medium intensity band
appearing at 345 and 350 nm for complexes 1 and 4, respectively,
is also indicative for a four-coordinated square planar geometry of
Cu(II) [51,52]. The two bands appearing at 220 & 240 nm and 222 &
261 nm for complexes 1 and 4, respectively, assigned to intraligand
charge transfer transitions. The geometries around the metal cen-
ters were further conﬁrmed by the ESR data.
The magnetic values of the complexes lay within the range
1.21–1.39 B.M. The subnormal, very low, magnetic moment values
of the metal complexes indicated that the copper centers are anti-
ferromagnetically coupled [53].
3.7. ESR spectra
Based on hyperﬁne and super hyperﬁne structures, the ESR
spectrum of metal complexes provides information about the envi-
ronment of the metal ion within the complexes, i.e., the geometry
and nature of the legating sites of the Schiff base and the metal.
The ESR spectra of the Cu(II) complexes 2, 4, 5 and 7were recorded
at room temperature. The shift of the signal in the low-ﬁeld region
to a slightly lower value indicates stronger metal–ligand bonding
[54]. The Cu(II) chelates 4 and 7 showed two peaks, one in the
low ﬁeld region and the other in the high ﬁeld region, from which
gll and g\ were calculated (Table 4). The gll values (<2.3) indicate
covalent character of the metal–ligand bonds [55]. The covalent
nature of the metal–ligand bond in the complex is further sup-
ported by the geff value [56], which was <2.0023. The value gll > g\
is well consistent with a primarily dx2–y2 ground state [57]. The
dX2–Y2 G.S. is characteristic of square planer, square pyramidal, tet-
rahedral or octahedral sterochemistry [58]. The gll/All value can be
used to determine the stereochemistry of the copper (II) complex
[59]. The range reported for square planar complexes is 105–
135 cm1 and for tetrahedrally distorted complexes 150–
250 cm1. The gll/All value is 111 cm1 for complex 4 in the range
of square planar and 187 cm1 for complex 7 in the range expected
for distorted tetrahedral complexes.
The ESR spectra of the other Cu (II) complexes (2 and 5) display
a small broad signal. The geff values are 1.72 and 1.68 for complexes
2 and 5, respectively. The negative deviation of geff value from the
value of the free electron (geff = 2.0023) may be attributed to cova-
lent character of the bond between the Cu(II) ion and the ligand
molecule [60]. The apparent broadening of the ESR signal can be
due to antiferromagnetic interaction of CuACu ions.
3.8. Molecular modeling
Since our trials to obtain a single crystals of the metal com-
plexes were unsuccessful so far, and in order to gain a better
understanding of geometrical structures of the investigated com-
plexes, molecular modeling studies have been done by means of
Hyperchem program package. Some selected bond lengths and an-
gles are listed in Table 5; the optimized structures, with atom
labeling scheme, of complexes 1 and 6 are represented in Figs. 4gll g\ gll/All geff
1.72
2.00 1.79 111
1.68
1.87 1.70 187
Table 5
Some selected bond distances (A) and bond angles () of metal complexes.
Bond Length (A) Bond Angle () Bond Length (A) Bond Angle ()
Complex 1 Complex 5
N1ACu2 1.8746 N1Cu2 Cl10 91.60 N8ACu9 1.9359 N8Cu9 O10 98.49
Cu2ACl10 2.1395 N1Cu2 Cl11 177.39 Cu9AO10 1.8980 N8Cu9 Cl28 108.89
Cu2ACl11 2.1550 N1Cu2 N3 92.16 Cu9ACl28 2.2388 N8Cu9 O29 119.18
Cu2AN3 1.8765 Cl10Cu2Cl11 85.88 Cu9AO29 1.9570 O10Cu9Cl28 114.70
N12ACu27 1.8727 Cl10Cu2N3 175.27 N16ACu21 1.9179 O10Cu9O29 104.59
N24ACu27 1.8728 Cl11Cu2N3 90.39 O20ACu21 1.8969 Cl28Cu9O29 110.63
C25AC26 1.4388 N12Cu27N24 175.92 Cu21ACl26 2.1992 N16Cu21O20 98.57
C25AC29 1.3715 N12Cu27Cl30 90.31 Cu21AO27 1.9608 N16Cu21Cl26 129.35
Cu27ACl30 2.1662 N12Cu27N28 91.59 C7AN8 1.3301 N16Cu21O27 112.98
Cu27AN28 1.8725 N24Cu27Cl30 93.08 N16AC17 1.3282 O20Cu21Cl26 111.43
N28AC29 1.4146 N24Cu27N28 85.09 C3AC4 1.3641 O20Cu21O27 103.21
N1AC5 1.3122 Cl30Cu27N28 177.53 C2AO10 1.3044 Cl26Cu21O27 99.05
Complex 2 Complex 6
C1AC2 1.4404 O7Cu8Cl11 103.90 N8ACu9 1.9362 N8Cu9 O10 98.31
C1AC6 1.3529 O7Cu8O12 97.76 Cu9AO10 1.8989 N8Cu9 Cl28 108.93
O7ACu8 1.8987 O7Cu8N9 100.20 Cu9ACl28 2.2382 N8Cu9 O29 119.20
Cu8ACl11 2.1935 Cl11Cu8O12 92.01 Cu9AO29 1.9567 O10Cu9Cl28 114.64
Cu8AO12 1.940 Cl11Cu8N9 146.48 N16ACu21 1.9187 O10Cu9O29 104.62
Cu8AN9 1.8960 O12Cu8N9 107.52 O20ACu21 1.8981 Cl28Cu9O29 110.73
N13ACu15 1.8714 N13Cu15O16 95.94 Cu21ACl26 2.2000 N16Cu21O20 98.40
Cu15AO16 1.8433 N13Cu15O25 121.13 Cu21AO27 1.9608 N16Cu21Cl26 129.29
Cu15AO25 1.9362 N13Cu15Cl26 142.67 C7AN8 1.3306 N16Cu21O27 112.84
Cu15ACl26 2.2230 O16Cu15O25 89.51 N16AC17 1.3293 O20Cu21Cl26 111.53
N1AC19 1.3119 O16Cu15Cl26 88.97 C3AC4 1.3751 O20Cu21O27 103.42
N9AC10 1.3694 O25Cu15Cl26 95.82 C4AO34 1.3664 Cl26Cu21O27 99.20
Complex 3 Complex 7
O7ACu8 1.9141 O7Cu8Cl11 108.48 N8ACu9 1.8627 N8Cu9O10 100.37
Cu8ACl11 2.2515 O7Cu8O12 104.60 N8AC11 1.4493 N8Cu9Cl28 150.23
Cu8AO12 1.9423 O7Cu8N9 100.75 Cu9AO10 1.8559 N8Cu9O29 113.46
Cu8AN9 1.9446 Cl11Cu8O12 108.73 Cu9ACl28 2.1874 O10Cu9Cl28 95.50
N13ACu14 1.8772 Cl11Cu8N9 113.48 Cu9AO29 1.9788 O10Cu9O29 100.56
Cu14AO15 1.8375 O12Cu8N9 119.60 C11AN12 1.5112 Cl28Cu9O29 87.84
Cu14AO23 1.9126 N13Cu14O15 95.68 N16ACu21 1.8627 N16Cu21O20 100.36
Cu14ACl24 2.2184 N13Cu14O23 118.50 O20ACu21 1.8559 N16Cu21Cl26 150.22
N9AC10 1.4081 N13Cu14Cl24 131.55 Cu21ACl26 2.1874 N16Cu21O27 113.52
N13AC18 1.3070 O15Cu14O23 88.91 Cu21AO27 1.9787 O20Cu21Cl26 95.51
C1AC6 1.3623 O15Cu14Cl24 87.33 C22AC23 1.3920 O20Cu21O27 100.45
C3AC4 1.4641 O23Cu14Cl24 109.89 C23AC24 1.4215 Cl26Cu21O27 87.82
Complex 4
N1AC5 1.4599 N7Cu8 N9 91.56
N7ACu8 1.8758 N7Cu8 Cl26 178.51
Cu8AN9 1.8766 N7Cu8 Cl27 92.96
Cu8ACl26 2.1585 N9Cu8 Cl26 89.84
Cu8ACl27 2.1493 N9Cu8 Cl27 173.00
N18ACu19 1.8762 Cl26Cu8Cl27 85.70
Cu19ACl24 2.1486 N6Cu19N18 91.57
Cu19ACl25 2.1582 N6Cu19Cl24 93.12
C20AC21 1.3742 N6Cu19Cl25 178.44
C21AC22 1.4083 N18Cu19Cl24 172.63
C22AC23 1.3781 N18Cu19Cl25 89.84
N9AC10 1.3867 Cl24Cu19Cl25 85.55
332 S. Amer et al. / Journal of Molecular Structure 1049 (2013) 326–335and 5. The complexes feature four-coordinated Cu centers with NN,
NNN (complexes 1 and 4) and NO (complexes 2, 3, 5, 6, and 7)
donor set of the Schiff base ligands.
For complexes 1 and 4, the copper atom is situated almost
exactly on the average plane deﬁned by the donor atoms of the
ligands and chloride ions. The cis angles around the Cu(II) ion
range from 85.09 to 93.08 and from 85.55 to 93.12 for
complexes 1 and 4, respectively; the trans angles ranging from
175.27 to 177.53 and from 172.63 to 178.51 for complexes 1
and 4, respectively, indicating square planar geometry with almost
no tetrahedral distortion [61,62].
For complexes 2, 3, 5, 6 and 7, the dihedral coordination around
the Cu(II) center, involving O, N and Cl atoms is distorted. The
degree of distortion from ideal tetrahedral geometry is given by
the minimum and maximum coordination angles around Cu. For
complexes 2, 3, 5, 6 and 7, the minimum angles are 88.97, 87.33,
98.49, 98.31 and 87.82, respectively. The maximum angles are123.40, 131.55, 129.35, 129.29 and 150.23 for complexes 2, 3, 5,
6 and 7 respectively. From Table 5, it is clear that the bond lengths
are found to be within the normal ranges obtained from the crystal
structure data [63]. The obtained results are in a good agreement
with the experimental results and hence strongly support them.
3.9. Antibacterial results
Taking into account the daily necessary quantity of Cu(II) in the
organism (2–3 mg per day), its distribution and metabolism in the
organism and toxicity, numerous simple or complex combinations
of copper are used in the treatment of a variety of diseases, includ-
ing inﬂammatory processes, cancer, ulcers, nervous system, and
heart diseases [28]. Some selected ligands, namely L1, L2, L5 and
L6, and their complexes were screened for their antibacterial activ-
ity against E. coli (G) and S. aureus (G+) and antifungal activity
against A. ﬂavus and C. albicans. The standard drugs, tetracycline
S. Amer et al. / Journal of Molecular Structure 1049 (2013) 326–335 333and amphotericin B, were also tested for their antibacterial and
antifungal activities at the same concentration (1 mg/ml) and con-
ditions of the test compounds (Table 6). From the obtained data,
the following results are pointed out:
1. All the tested compounds, except for complex 2, are found to
have no biological activity against A. ﬂavus.
2. With C. albican, L2, complex 2 and 6 showed moderate activity
while the other compounds showed no activity.Fig. 4. Computational str
Fig. 5. Computational str
Table 6
Antimicrobial activities of the investigated ligands and their Cu(II) complexes.
Compound Inhibition zone diameter (mm/mg sample)a
E. coli (G) S. aureus (G+)
Control: DMSO NAb NA
Tetracyclinec 33.0 ± 0.3 30.0 ± 0.4
Amphotericin Bd – –
L1 NA NA
1 12.0 ± 0.3 12.0 ± 0.2
L2 12.0 ± 0.3 13.0 ± 0.2
2 13.0 ± 0.3 12.0 ± 0.2
L5 12.0 ± 0.3 13.0 ± 0.4
5 13.0 ± 0.4 14.0 ± 0.2
L6 11.0 ± 0.2 12.0 ± 0.3
6 15.0 ± 0.5 15.0 ± 0.4
a Diameter of zone of inhibition (mm) including well diameter 8 mm, each experimen
b Not active.
c (Antibacterial agent).
d (Antifungal agent).3. All the tested compounds showed a moderate activity against
the bacterial strains E. coli and S. aureus, except for L1 which
is inactive against the both types of bacteria.
4. On comparing the activity of the tested complexes with their
parent ligands, the obtained data indicated that the activity is
increased upon complexation (except for L2 and complex 2
against S. aureus and C. albicans). This result may be explained
by on the basis of chelating theory [64], which stated that che-
lating reduces the polarity of the ligand and the central metalucture of complex 1.
ucture of complex 6.
A. ﬂavus (Fungus) C. albicans (Fungus)
NA NA
– –
20.0 ± 0.2 20.0 ± 0.1
NA NA
NA NA
NA 17.0 ± 0.2
16.0 ± 0.4 11.0 ± 0.2
NA NA
NA NA
NA NA
NA 12.0 ± 0.3
t has been conducted three times at least.
Table 7
In vitro antitumor activities of complex 2 against MCF7, HCT116 and HEPG2 cell lines.
Compound IC50 (lg/ml)
MCF7 HCT116 HEPG2
2 10.3 9.8 8.7
Doxa 4.35 4.6 3.1
a Doxorubicin, standard cytotoxin drug.
Fig. 6. In vitro cytotoxicity of 2 and doxorubicin (Dox) drug against human breast
cancer cell line (MCF7).
Fig. 7. In vitro cytotoxicity of 2 and doxorubicin (Dox) drug against human colon
carcinoma (HCT116).
Fig. 8. In vitro cytotoxicity of 2 and doxorubicin (Dox) drug against against human
liver Carcinoma (HEPG2).
334 S. Amer et al. / Journal of Molecular Structure 1049 (2013) 326–335atom because the delocalization of p-electrons over the whole
chelate ring increases, which favor permeation of the com-
plexes through the lipid layer of the cell membrane.
5. Finally, the variation in the activity of different compounds
against various organisms depends either on the impermeabil-
ity of the cells of the microbes or differences in ribosome in
microbial cells [65].
3.10. Antitumor results
In vitro antitumor activity of complex 2, as a model example,
against three cancer cell lines; breast carcinoma (MCF7), colon
carcinoma (HCT116) and liver Carcinoma (HEPG2) cell lines was
conducted in our study. The values of IC50, compared with thestandard drug doxorubicin are collected in Table 7 and revealed
that compound 2 showed activity against all the tested cell lines.
Figs. 6–8 represents the cytotoxicity of complex 2 and doxorubicin
(Dox) drug against the three cell lines, using different concentra-
tions of 2 or Dox. Untreated cells were used as a control. Each data
point is an average of three independent experiments and ex-
pressed as M ± SD. From these ﬁgures it is clear that complex 2
inhibited the growth of the tested cells in a dose dependent man-
ner. Speciﬁcally, compound 2 showed an inhibition of cell viability
and gave an IC50 values of 10.3, 9.8 and 8.7 lg/ml against MCF7,
HCT116 and HEPG2, respectively, compared with IC50 values of
4.6, 3.1, 4.35 against HCT116, HEPG2 and MCF7, respectively, for
the standard cytotoxin drug doxorubicin. According to Shier [66],
the compounds exhibiting IC50 activity within the range of 10–
25 lg/ml are considered weak anticancer drugs, while those of
IC50 activity between 5 and 10 lg/ml are moderate and compounds
of activity below 5.00 lg/ml are considered strong agents. Accord-
ingly, this complex showed a moderate activity against the studied
cell lines; the order of activity is MCF7 > HCT116 > HEPG2.4. Conclusion
In this study, seven new Cu(II) complexes with Schiff bases
derived from 7H-2,6-diaminopurine and 4H-3,5-diamino-1,2,4-tri-
azole were synthesized and characterized by elemental, mass spec-
tra, thermal analyses, IR, spectral, and magnetic data. The
electronic and ESR spectral studies suggested distorted tetrahedral
geometry for all complexes, except for complex 1 and 4which have
square planar geometry. The obtained results are supported by 3D
molecular modeling of complexes. The results of the antibacterial
activity of the tested ligands and their complexes showed moder-
ate activity against E. coli and S. aureus when compared with the
standard drug, tetracycline. In vitro antitumor activity of complex
2 showed a moderate activity against the studied cell lines; the or-
der of activity is MCF7 > HCT116 > HEPG2.References
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